Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Vidaud

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2007
Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1Pascale Lévy, Hugues Ripoche, Ingrid Laurendeau, et al.
Journal of Hepatology|January 16, 2007
High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapyRami Moucari, Marie-Pierre Ripault, Valérie Oulès, et al.
Cancer Research|March 3, 2006
Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosisAngela Sutton, Pierre Nahon, Dominique Pessayre, et al.
Stroke|March 26, 2019
Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya AngiopathyLou Grangeon, Stéphanie Guey, Jan Claudius Schwitalla, et al.
Molecular Cancer Therapeutics|April 22, 2010
Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cellsMaria Serova, Lucile Astorgues-Xerri, Ivan Bieche, et al.
Gastroenterology|December 7, 2007
Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
Human Mutation|August 6, 2013
NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceAudrey Sabbagh, Eric Pasmant, Apolline Imbard, et al.
Journal of the Endocrine Society|July 6, 2023
Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1Hippolyte Dupuis, Benjamin Chevalier, Catherine Cardot-Bauters, et al.
Nature Genetics|November 23, 2006
Conservation of hotspots for recombination in low-copy repeats associated with the NF1 microdeletionThomas De Raedt, Matthew Stephens, Ine Heyns, et al.
Journal of Neuropathology and Experimental Neurology|December 17, 2009
Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesisEric Pasmant, Nicolas Ortonne, Laure Rittié, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2007
Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1Pascale Lévy, Hugues Ripoche, Ingrid Laurendeau, et al.
Journal of Hepatology|January 16, 2007
High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapyRami Moucari, Marie-Pierre Ripault, Valérie Oulès, et al.
Cancer Research|March 3, 2006
Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosisAngela Sutton, Pierre Nahon, Dominique Pessayre, et al.
Stroke|March 26, 2019
Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya AngiopathyLou Grangeon, Stéphanie Guey, Jan Claudius Schwitalla, et al.
Molecular Cancer Therapeutics|April 22, 2010
Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cellsMaria Serova, Lucile Astorgues-Xerri, Ivan Bieche, et al.
Gastroenterology|December 7, 2007
Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
Human Mutation|August 6, 2013
NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceAudrey Sabbagh, Eric Pasmant, Apolline Imbard, et al.
Journal of the Endocrine Society|July 6, 2023
Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1Hippolyte Dupuis, Benjamin Chevalier, Catherine Cardot-Bauters, et al.
Nature Genetics|November 23, 2006
Conservation of hotspots for recombination in low-copy repeats associated with the NF1 microdeletionThomas De Raedt, Matthew Stephens, Ine Heyns, et al.
Journal of Neuropathology and Experimental Neurology|December 17, 2009
Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesisEric Pasmant, Nicolas Ortonne, Laure Rittié, et al.
Pageof 9